Total Payments
$7,532
2024 Payments
$1,557
Companies
49
Transactions
425
Medicare Patients
328
Medicare Billing
$50,838
Payment Breakdown by Category
Food & Beverage$7,418 (98.5%)
Education$114.08 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,418 | 423 | 98.5% |
| Education | $114.08 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,016 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $525.23 | 25 | $0 (2024) |
| PFIZER INC. | $518.32 | 38 | $0 (2024) |
| Genentech USA, Inc. | $474.92 | 23 | $0 (2024) |
| Merck Sharp & Dohme LLC | $462.48 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $406.54 | 50 | $0 (2019) |
| Daiichi Sankyo Inc. | $359.80 | 17 | $0 (2024) |
| Eisai Inc. | $354.75 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $324.54 | 20 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $285.73 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,557 | 66 | Merck Sharp & Dohme LLC ($224.88) |
| 2023 | $1,893 | 84 | AstraZeneca Pharmaceuticals LP ($246.02) |
| 2022 | $1,417 | 71 | AstraZeneca Pharmaceuticals LP ($153.84) |
| 2019 | $367.15 | 33 | Janssen Pharmaceuticals, Inc ($149.15) |
| 2018 | $1,135 | 85 | Novartis Pharmaceuticals Corporation ($409.09) |
| 2017 | $1,163 | 86 | Novartis Pharmaceuticals Corporation ($340.39) |
All Payment Transactions
425 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.59 | General |
| 12/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/20/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: BioOncology | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Oncology | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/09/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Oncology | ||||||
| 09/24/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Oncology | ||||||
| 09/18/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.64 | General |
| 09/09/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.11 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 196 | 361 | $118,752 | $28,683 |
| 2022 | 4 | 132 | 257 | $86,212 | $22,155 |
Total Patients
328
Total Services
618
Medicare Billing
$50,838
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 125 | $46,250 | $11,113 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 152 | $38,456 | $10,327 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $17,625 | $3,852 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $15,708 | $3,132 | 19.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 31 | $713.00 | $260.40 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 97 | $35,890 | $9,786 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 102 | $25,806 | $7,194 | 27.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $15,540 | $3,142 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $8,976 | $2,034 | 22.7% |
About Dr. Ashwin Sheelvanth, MD
Dr. Ashwin Sheelvanth, MD is a Hematology & Oncology healthcare provider based in Zion, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134115769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashwin Sheelvanth, MD has received a total of $7,532 in payments from pharmaceutical and medical device companies, with $1,557 received in 2024. These payments were reported across 425 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,418).
As a Medicare-enrolled provider, Sheelvanth has provided services to 328 Medicare beneficiaries, totaling 618 services with total Medicare billing of $50,838. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Zion, IL
- Active Since 09/20/2005
- Last Updated 08/27/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1134115769
Products in Payments
- AFINITOR (Drug) $544.69
- KEYTRUDA (Biological) $451.31
- XARELTO (Drug) $406.54
- Lenvima (Drug) $339.75
- OPDIVO (Biological) $324.54
- LIBTAYO (Biological) $298.54
- KISQALI (Drug) $232.12
- SUTENT (Drug) $221.64
- INJECTAFER (Drug) $182.54
- LYNPARZA (Drug) $151.41
- Avastin (Biological) $145.36
- TAGRISSO (Drug) $140.11
- Udenyca (Biological) $133.29
- IMBRUVICA (Drug) $130.91
- KRAZATI (Drug) $125.46
- IBRANCE (Drug) $111.87
- INLYTA (Drug) $110.25
- Enhertu (Drug) $104.72
- Abraxane (Drug) $104.51
- DOPTELET (Drug) $99.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Zion
Tulio Rodriguez, M.d, M.D
Hematology & Oncology — Payments: $346,080
Hematology & Oncology $346,080
Walter Stadler, Md, MD
Hematology & Oncology — Payments: $163,877
Hematology & Oncology $163,877
Dr. Ajaz Khan, M.d, M.D
Hematology & Oncology — Payments: $2,745
Hematology & Oncology $2,745
Evan Pisick, M.d, M.D
Hematology & Oncology — Payments: $1,117
Hematology & Oncology $1,117
Rohit Shah, M.d, M.D
Hematology & Oncology — Payments: $205.80
Hematology & Oncology $205.80